The PDZ-Binding Motif of Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Is a Determinant of Viral Pathogenesis

A recombinant severe acute respiratory syndrome coronavirus (SARS-CoV) lacking the envelope (E) protein is attenuated in vivo. Here we report that E protein PDZ-binding motif (PBM), a domain involved in protein-protein interactions, is a major determinant of virulence. Elimination of SARS-CoV E protein PBM by using reverse genetics caused a reduction in the deleterious exacerbation of the immune response triggered during infection with the parental virus and virus attenuation. Cellular protein syntenin was identified to bind the E protein PBM during SARS-CoV infection by using three complementary strategies, yeast two-hybrid, reciprocal coimmunoprecipitation and confocal microscopy assays. Syntenin redistributed from the nucleus to the cell cytoplasm during infection with viruses containing the E protein PBM, activating p38 MAPK and leading to the overexpression of inflammatory cytokines. Silencing of syntenin using siRNAs led to a decrease in p38 MAPK activation in SARS-CoV infected cells, further reinforcing their functional relationship. Active p38 MAPK was reduced in lungs of mice infected with SARS-CoVs lacking E protein PBM as compared with the parental virus, leading to a decreased expression of inflammatory cytokines and to virus attenuation. Interestingly, administration of a p38 MAPK inhibitor led to an increase in mice survival after infection with SARS-CoV, confirming the relevance of this pathway in SARS-CoV virulence. Therefore, the E protein PBM is a virulence domain that activates immunopathology most likely by using syntenin as a mediator of p38 MAPK induced inflammation.

• Publication year

  2014

• Venue

  PLoS Pathogens

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.ppat.1004320PMID 25122212PMCID 4133396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis

  2014cited by this paper
• Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury

  2013cited by this paper
• Hospital outbreak of Middle East respiratory syndrome coronavirus.

  2013cited by this paper
• Analysis of SARS-CoV E protein ion channel activity by tuning the protein and lipid charge

  2013cited by this paper
• The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines

  2013cited by this paper
• Inhibition of p38 Mitogen-activated Protein Kinase Impairs Influenza Virus-induced Primary and Secondary Host Gene Responses and Protects Mice from Lethal H5N1 Infection

  2013cited by this paper
• Inhibition of NF-κB-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival

  2013cited by this paper
• Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein

  2013cited by this paper
• PDZ‐containing proteins as targets in human pathologies

  2012cited by this paper
• The Role of Flexibility and Conformational Selection in the Binding Promiscuity of PDZ Domains

  2012cited by this paper
• Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.

  2012cited by this paper
• A Single Polar Residue and Distinct Membrane Topologies Impact the Function of the Infectious Bronchitis Coronavirus E Protein

  2012cited by this paper
• Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

  2012cited by this paper
• The PDZ protein discs‐large (DLG): the ‘Jekyll and Hyde’ of the epithelial polarity proteins

  2012cited by this paper
• Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids

  2012cited by this paper
• Incubation period as part of the case definition of severe respiratory illness caused by a novel coronavirus.

  2012cited by this paper
• PDZ domains: the building blocks regulating tumorigenesis.

  2011cited by this paper
• Emerging Theme: Cellular PDZ Proteins as Common Targets of Pathogenic Viruses

  2011cited by this paper
• Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Regulates Cell Stress Response and Apoptosis

  2011cited by this paper
• Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein

  2011cited by this paper
• Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease

  2010cited by this paper
• The SARS coronavirus E protein interacts with the PALS1 and alters tight junction formation and epithelial morphogenesis

  2010influential reference
• Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of Nuclear Factor-κB

  2010cited by this paper
• SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism

  2010cited by this paper
• Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates

  2010cited by this paper
• The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated

  2010cited by this paper
• Identification of specificity and promiscuity of PDZ domain interactions through their dynamic behavior

  2009cited by this paper
• Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection

  2009cited by this paper
• Rhesus Theta-Defensin Prevents Death in a Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Pulmonary Disease

  2009influential reference
• The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

  2009cited by this paper
• Vaccines for Severe Acute Respiratory Syndrome Virus and Other Coronaviruses

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV

  2008cited by this paper
• Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice

  2008cited by this paper
• mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.

  2007influential reference
• Role of the Coronavirus E Viroporin Protein Transmembrane Domain in Virus Assembly

  2007cited by this paper
• A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice

  2007cited by this paper
• Detection of Group 1 Coronaviruses in Bats in North America

  2007cited by this paper
• A Severe Acute Respiratory Syndrome Coronavirus That Lacks the E Gene Is Attenuated In Vitro and In Vivo

  2006cited by this paper
• Construction of a Severe Acute Respiratory Syndrome Coronavirus Infectious cDNA Clone and a Replicon To Study Coronavirus RNA Synthesis

  2006cited by this paper
• Act globally, think locally: systems biology addresses the PDZ domain.

  2006cited by this paper
• Molecular diversity of coronaviruses in bats

  2006cited by this paper
• Model of a Putative Pore: The Pentameric α-Helical Bundle of SARS Coronavirus E Protein in Lipid Bilayers

  2006cited by this paper
• Subcellular localization and membrane association of SARS-CoV 3a protein

  2005cited by this paper
• Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein.

  2005cited by this paper
• Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E.

  2005cited by this paper
• Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats.

  2005cited by this paper
• Protein interaction mapping: a Drosophila case study.

  2005cited by this paper
• Bats Are Natural Reservoirs of SARS-Like Coronaviruses

  2005cited by this paper
• Early Enhanced Expression of Interferon-Inducible Protein-10 (CXCL-10) and Other Chemokines Predicts Adverse Outcome in Severe Acute Respiratory Syndrome

  2005cited by this paper
• A Novel Severe Acute Respiratory Syndrome Coronavirus Protein, U274, Is Transported to the Cell Surface and Undergoes Endocytosis

  2004cited by this paper
• Altered p38 Mitogen-Activated Protein Kinase Expression in Different Leukocytes with Increment of Immunosuppressive Mediators in Patients with Severe Acute Respiratory Syndrome1

  2004cited by this paper
• Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

  2004cited by this paper
• Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage

  2003cited by this paper
• The Severe Acute Respiratory Syndrome

  2003cited by this paper
• Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

  2003cited by this paper
• Identifying differentially expressed genes using false discovery rate controlling procedures

  2003cited by this paper
• Lung pathology of fatal severe acute respiratory syndrome

  2003cited by this paper
• p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

  2003cited by this paper
• PDZ Domains: Structural Modules for Protein Complex Assembly*

  2002cited by this paper
• The Neural Cell Recognition Molecule Neurofascin Interacts with Syntenin-1 but Not with Syntenin-2, Both of Which Reveal Self-associating Activity*

  2001cited by this paper
• Mechanism and role of PDZ domains in signaling complex assembly.

  2001cited by this paper
• The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein.

  2001cited by this paper
• SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.

  2000cited by this paper
• Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase.

  1999cited by this paper
• Analysis of Constructed E Gene Mutants of Mouse Hepatitis Virus Confirms a Pivotal Role for E Protein in Coronavirus Assembly

  1998cited by this paper
• Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens

  1997cited by this paper
• Evidence for PDZ domains in bacteria, yeast, and plants

  1997cited by this paper
• SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1

  1995influential reference
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper

• Syntenins at the crossroads of host-virus interactions.

  2026cites this paper
• Interaction of coronavirus E protein with BRD2 plays important regulatory roles in viral replication and induction of pro-inflammatory response

  2026cites this paper
• The antiviral effects and underlying mechanisms of probiotics on viral infections.

  2025cites this paper
• Phosphorylation Modifications and Their Role in Viral Pneumonia: Mechanisms and Therapeutic Implications

  2025cites this paper
• Deletion of the Envelope gene attenuates SARS-CoV-2 infection by altered Spike localization and increased cell-to-cell transmission

  2025cites this paper
• The SARS-CoV-2 envelope PDZ binding motif acts as a virulence factor disrupting host’s epithelial cell–cell junctions

  2025influential citation
• Comparative analysis of human coronavirus E-peptide-PALS-1 interactions using molecular dynamic simulations

  2025cites this paper
• Evolutionarily divergent nidovirus with an exceptionally large genome identified in Pacific oysters undergoing mass mortality

  2025cites this paper
• Inhibitors of Tax1‐PDZ Interactions Block HTLV‐1 Viral Transmission by Changing EV Composition

  2025cites this paper
• HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2

  2025cites this paper
• Advances in Viroporin Function and Structure: A Comparative Analysis of Alphavirus 6K with Well-Characterized Viroporins

  2025cites this paper
• Modeling of host PDZ-dependent interactions with SARS-CoV-2 Envelope protein and changes in PDZ proteins expression in macrophages and dendritic cells.

  2024cites this paper
• Membrane Activity and Viroporin Assembly for the SARS-CoV-2 E Protein Are Regulated by Cholesterol

  2024cites this paper
• IGSF1: a biomarker for predicting prognosis, immunotherapy response, and drug candidates in COVID-19 combined hepatocellular carcinoma

  2024cites this paper
• Porcine Epidemic Diarrhea: Insights and Progress on Vaccines

  2024cites this paper
• SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl− concentration

  2024cites this paper
• SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression

  2024cites this paper
• The PDZ Domain of the E Protein in SARS-CoV Induces Carcinogenesis and Poor Prognosis in LUAD.

  2024cites this paper
• Advancing the field of viroporins—Structure, function and pharmacology: IUPHAR Review 39

  2024cites this paper
• The mutual lipid-mediated effect of the transmembrane domain of SARS-CoV-2 E-protein and glycyrrhizin nicotinate derivatives on the localization in the lipid bilayer.

  2024cites this paper
• Structural proteins of human coronaviruses: what makes them different?

  2024cites this paper
• Membrane remodeling and trafficking piloted by SARS-CoV-2.

  2024cites this paper
• Expression and immunogenicity of non-structural protein 8 of porcine epidemic diarrhea virus

  2024cites this paper
• Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models

  2024cites this paper
• Molecular dynamic simulations to explore the broad-spectrum activity of the inhibitor PF-07321332 against human coronavirus.

  2024cites this paper
• Molecular Dynamics Simulation of SARS-CoV-2 E Ion Channel: The Study of Lone Protein and its Conformational Changes in Complex with Potential Cage Inhibitors.

  2024cites this paper
• Interaction between SARS-CoV PBM and Cellular PDZ Domains Leading to Virus Virulence

  2024influential citation
• The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target

  2023cites this paper
• Channel activity of SARS-CoV-2 viroporin ORF3a inhibited by adamantanes and phenolic plant metabolites

  2023cites this paper
• PDZ interaction of the GABA transporter GAT1 with the syntenin-1 in Neuro-2a cells.

  2023cites this paper
• Therapeutic Targets in the Virological Mechanism and in the Hyperinflammatory Response of Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)

  2023cites this paper
• A Significant Difference in Core PDZ Interactivity of SARS-CoV, SARS-CoV2 and MERS-CoV Protein E Peptide PDZ Motifs In Vitro

  2023influential citation
• A calorimetric and structural analysis of cooperativity in the thermal unfolding of the PDZ tandem of human Syntenin-1.

  2023cites this paper
• SARS-CoV-2 Envelope protein triggers depression and dysosmia via TLR2 mediated neuroinflammation

  2023cites this paper
• SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators

  2023cites this paper
• Infection routes, invasion mechanisms, and drug inhibition pathways of human coronaviruses on the nervous system

  2023cites this paper
• Polarity in respiratory development, homeostasis and disease.

  2023cites this paper
• SARS-CoV-2 envelope protein triggers depression-like behaviors and dysosmia via TLR2-mediated neuroinflammation in mice

  2023cites this paper
• Identification of common genetic characteristics of rheumatoid arthritis and major depressive disorder by bioinformatics analysis and machine learning

  2023cites this paper
• M Protein from Dengue virus oligomerizes to pentameric channel protein: in silico analysis study

  2023cites this paper
• Deletion of a 7-amino-acid region in the porcine epidemic diarrhea virus envelope protein induces higher type I and III interferon responses and results in attenuation in vivo

  2023cites this paper
• SARS-CoV-2 envelope protein alters calcium signaling via SERCA interactions

  2023cites this paper
• Comparative Pathogenesis of Severe Acute Respiratory Syndrome Coronaviruses.

  2023cites this paper
• SARS-CoV-2 envelope protein and its relationship to the membrane protein

  2023cites this paper
• Hexamethylene amiloride binds the SARS‐CoV‐2 envelope protein at the protein–lipid interface

  2023cites this paper
• Identification of Host PDZ-Based Interactions with the SARS-CoV-2 E Protein in Human Monocytes

  2023influential citation
• Reply to: Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection

  2023cites this paper
• A short sequence in the tail of SARS-CoV-2 envelope protein controls accessibility of its PDZ-binding motif to the cytoplasm

  2023cites this paper
• Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells

  2023cites this paper
• Amantadine for COVID-19 treatment (ACT study): a randomized, double-blinded, placebo-controlled clinical trial

  2023cites this paper
• Viral manipulation of cell polarity signalling.

  2023cites this paper
• In Silico Screening of Drugs That Target Different Forms of E Protein for Potential Treatment of COVID-19

  2023cites this paper
• Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2

  2023cites this paper
• Atomic structure of the open SARS-CoV-2 E viroporin

  2023cites this paper
• pH- and Calcium-Dependent Aromatic Network in the SARS-CoV-2 Envelope Protein.

  2022cites this paper
• Therapeutic agents for ARDS

  2022cites this paper
• Structural basis for targeting the human T-cell leukemia virus Tax oncoprotein and syntenin-1 interaction using a small molecule

  2022cites this paper
• Structural proteins of SARS-CoV-2

  2022cites this paper
• The Flexible, Extended Coil of the PDZ-Binding Motif of the Three Deadly Human Coronavirus E Proteins Plays a Role in Pathogenicity

  2022cites this paper
• Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern

  2022cites this paper
• Antiviral Potential of Plants against COVID-19 during Outbreaks—An Update

  2022influential citation
• An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants

  2022cites this paper
• Nature of viruses and pandemics: Coronaviruses

  2022cites this paper
• Porcine epidemic diarrhea virus E protein inhibits type I interferon production through endoplasmic reticulum stress response (ERS)-mediated suppression of antiviral proteins translation.

  2022cites this paper
• The Genetic Stability, Replication Kinetics and Cytopathogenicity of Recombinant Avian Coronaviruses with a T16A or an A26F Mutation within the E Protein Is Cell-Type Dependent

  2022cites this paper
• Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques

  2022cites this paper
• Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19

  2022cites this paper
• A Syntenin Inhibitor Blocks Endosomal Entry of SARS-CoV-2 and a Panel of RNA Viruses

  2022cites this paper
• The role of severe acute respiratory syndrome coronavirus 2 viroporins in inflammation

  2022cites this paper
• The Reassessed Potential of SARS-CoV-2 Attenuation for COVID-19 Vaccine Development—A Systematic Review

  2022cites this paper
• Functions of Viroporins in the Viral Life Cycle and Their Regulation of Host Cell Responses

  2022cites this paper
• SARS-CoV-2 Harnesses Host Translational Shutoff and Autophagy To Optimize Virus Yields: the Role of the Envelope (E) Protein

  2022cites this paper
• Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism

  2022cites this paper
• Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19

  2022cites this paper
• The SARS-CoV-2 envelope (E) protein forms a calcium- and voltage-activated calcium channel

  2022cites this paper
• Interactions of Severe Acute Respiratory Syndrome Coronavirus 2 Protein E With Cell Junctions and Polarity PSD-95/Dlg/ZO-1-Containing Proteins

  2022cites this paper
• Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2

  2022cites this paper
• Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology

  2022cites this paper
• Lactobacillus rhamnosus Restores Antiviral Signaling and Attenuates Cytokines Secretion from Human Bronchial Epithelial Cells Exposed to Cigarette Smoke and Infected with SARS-CoV-2

  2022cites this paper
• Virtual screening and molecular dynamics simulation study of plant protease inhibitors against SARS-CoV-2 envelope protein

  2022cites this paper
• Structure of SARS CoV2

  2021cites this paper
• Biophysical characterization of the SARS-CoV-2 E protein — Source link

  2021cites this paper
• Genetic Arguments for the Prevention of Severe Forms of COVID-19 through Moderate-Intensity Exercise

  2021cites this paper
• Induction of the Proinflammatory Chemokine Interleukin-8 Is Regulated by Integrated Stress Response and AP-1 Family Proteins Activated during Coronavirus Infection

  2021cites this paper
• The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences

  2021cites this paper
• Ligand-Based Approaches for the Development of Drugs Against SARS-CoV-2

  2021cites this paper
• Evolution, Interspecies Transmission, and Zoonotic Significance of Animal Coronaviruses

  2021cites this paper
• Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation

  2021cites this paper
• Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis

  2021cites this paper
• SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses

  2021influential citation
• Probing effects of the SARS-CoV-2 E protein on membrane curvature and intracellular calcium

  2021cites this paper
• Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week

  2021cites this paper
• Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19

  2021cites this paper
• Host PDZ‐containing proteins targeted by SARS‐CoV‐2

  2021cites this paper
• Chemokine Regulation During Epidemic Coronavirus Infection

  2021cites this paper
• Viral PDZ Binding Motifs Influence Cell Behavior Through the Interaction with Cellular Proteins Containing PDZ Domains.

  2021cites this paper
• The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis

  2021cites this paper
• A parsimonious approach for recognizing SARS‐CoV‐2 and host interactions

  2021cites this paper
• Computational Drug Repurposing for the Development of Drugs Against Coronaviruses

  2021cites this paper
• ER-export and ARFRP1/AP-1–dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication

  2021cites this paper